Clinical Trial: Iloprost in Acute Respiratory Distress Syndrome
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Therapeutic Iloprost for the Treatment of Acute Respiratory Distress Syndrome (ARDS) (the ThIlo-Trial)
Brief Summary: The patients will be randomized into one of two groups. Both groups will receive standard care as is state of the art. The intervention group will receive Iloprost nebulized as inhalative therapy.
Detailed Summary:
Sponsor: University Hospital Tuebingen
Current Primary Outcome: overall survival [ Time Frame: 90 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University Hospital Tuebingen
Dates:
Date Received: April 6, 2017
Date Started: June 2018
Date Completion: January 2021
Last Updated: April 25, 2017
Last Verified: April 2017